Primary Rectal Tumor With Extensive Choriocarcinoma Differentiation in a Woman With Lung, Liver and Disseminated Peritoneal Disease: A Primary Rectal Adenocarcinoma With Extensive Choriocarcinoma Differentiation or Primary Rectal Choriocarcinoma?

被引:0
|
作者
Machado, Isidro [1 ,2 ,3 ,4 ,9 ]
La Piedra, Maria del Carmen Martinez [5 ]
de Juan, Fernando Martinez [5 ]
de Alcantara, Fernanda-Maia [5 ]
Claramunt, Reyes [6 ]
Lopez-Guerrero, Jose Antonio [6 ]
Marhuenda, Ana [7 ]
Melian, Marcos [8 ]
机构
[1] Inst Valenciano Oncol, Valencia, Spain
[2] Hosp QuironSalud, Pathol Dept, Patologika Lab, Valencia, Spain
[3] Univ Valencia, Pathol Dept, Valencia, Spain
[4] Canc CIBER CIBERONC, Madrid, Spain
[5] Inst Valenciano Oncol, Gastroenterol Dept, Valencia, Spain
[6] Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain
[7] Inst Valenciano Oncol, Radiol Dept, Valencia, Spain
[8] Inst Valenciano Oncol, Oncol Dept, Valencia, Spain
[9] Inst Valenciano Oncol, Dept Patol, Blasco Ibanez 17, Valencia 46009, Spain
关键词
primary rectal choriocarcinoma; immunohistochemistry; molecular analysis; CARCINOMA;
D O I
10.1177/10668969231204956
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary rectal adenocarcinoma with extensive choriocarcinomatous differentiation is a rare neoplasm, with only sporadic cases reported worldwide. The prognosis is typically poor, and no standard therapy has been established for this tumor. We report a case of a 63-year-old woman who presented with lower abdominal and pelvic discomfort, as well as rectal bleeding. Endoscopy revealed a rectal tumor. She was diagnosed with primary rectal adenocarcinoma with extensive choriocarcinomatous differentiation, accompanied by liver metastasis and peritoneal carcinomatosis. The immunohistochemical profile demonstrated strong and diffuse positivity for keratin (AE1/AE3), beta-human chorionic gonadotropin (beta-HCG), p53, MYC, p16, and Ki-67. Molecular analysis indicated mutations in KRAS, TP53, and PI3KCA. Despite the tumor's profile, the serum beta-HCG level was not elevated. A chemotherapy regimen for metastatic colorectal adenocarcinoma was initiated, but there was a poor response, with rapid tumor progression. The patient survived for only 5 months postdiagnosis. We discuss the histopathological, immunohistochemical, and molecular findings, emphasizing their relevance to the differential diagnosis of neoplasms with choriocarcinomatous differentiation.
引用
收藏
页码:976 / 981
页数:6
相关论文
共 50 条
  • [41] Second primary common bile duct neuroendocrine tumor after 10 years in a patient with rectal adenocarcinoma: A case report
    Ebrahimian, Saba
    Varaki, Sakineh Soleimani
    Esfahani, Farid Nasr
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2024, 15 (02) : 360 - 363
  • [42] Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease
    Nash, GM
    Saltz, LB
    Kemeny, NE
    Minsky, B
    Sharma, S
    Schwartz, GK
    Ilson, DH
    O'Reilly, E
    Kelsen, DP
    Nathanson, DR
    Weiser, M
    Guillem, JG
    Wong, WD
    Cohen, AM
    Paty, PB
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) : 954 - 960
  • [43] Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease
    Garrett M. Nash
    Leonard B. Saltz
    Nancy E. Kemeny
    Bruce Minsky
    Sunil Sharma
    Gary K. Schwartz
    David H. Ilson
    Eileen O’Reilly
    David P. Kelsen
    Daniel R. Nathanson
    Martin Weiser
    Jose G. Guillem
    W. Douglas Wong
    Alfred M. Cohen
    Philip B. Paty
    Annals of Surgical Oncology, 2002, 9 : 954 - 960
  • [44] DISCORDANCE IN HISTOLOGICAL SIGNS OF TUMOR REGRESSION BETWEEN PRIMARY RECTAL ADENOCARCINOMA AND THE MESORECTAL LYMPH NODES FOLLOWING NEOADJUVANT CHEMORADIATION.
    Edden, Y.
    Wexner, S.
    Shawki, S.
    Canedo, J.
    Nogueras, J.
    Berho, M.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 637 - 638
  • [45] Value of Primary Rectal Tumor PET/MRI in the Prediction of Synchronic Metastatic Disease (vol 24, pg 453, 2021)
    Queiroz, Marcelo A.
    Ortega, Cinthia D.
    Ferreira, Felipe R.
    Capareli, Fernanda C.
    Nahas, Sergio C.
    Cerri, Giovanni G.
    Buchpiguel, Carlos A.
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (03) : 464 - 465
  • [46] ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
    Maki, Harufumi
    Ayabe, Reed I. I.
    Nishioka, Yujiro
    Konishi, Tsuyoshi
    Newhook, Timothy E. E.
    Cao, Hop S. Tran S.
    Chun, Yun Shin
    Tzeng, Ching-Wei D.
    You, Y. Nancy
    Vauthey, Jean-Nicolas
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5403 - 5404
  • [47] Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis
    Renz, Paul
    Wegner, Rodney E.
    Hasan, Shaakir
    Brookover, Robert
    Finley, Gene
    Monga, Dulabh
    Raj, Moses
    McCormick, James
    Kirichenko, Alexander
    CLINICAL COLORECTAL CANCER, 2019, 18 (02) : E237 - E243
  • [48] ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
    Harufumi Maki
    Reed I. Ayabe
    Yujiro Nishioka
    Tsuyoshi Konishi
    Timothy E. Newhook
    Hop S. Tran Cao
    Yun Shin Chun
    Ching-Wei D. Tzeng
    Y. Nancy You
    Jean-Nicolas Vauthey
    Annals of Surgical Oncology, 2023, 30 : 5403 - 5404
  • [49] The Role of PET/MRI Parameters of Primary Tumor in Predicting Pathological Response and Recurrent Disease after Neoadjuvant Therapy in Rectal Cancer
    Ibis, E. Tuncay
    Demir, S.
    Aydos, U.
    Balci, E.
    Atay, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S517 - S517
  • [50] Pelvic radiotherapy in combination with radical resection of the primary tumor improves survival in patients with metastatic rectal adenocarcinoma: A national cancer database analysis (NCDB).
    Renz, Paul B.
    Hasan, Shaakir
    Wegner, Rodney E.
    Finley, Gene Grant
    Monga, Dulabh K.
    Raj, Moses S.
    McCormick, James
    Kirichenko, Alexander V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)